NCT04068532View on ClinicalTrials.gov

A Study to Explore Pharmacodynamic Effects of BIIB104 on Brain Circuitry in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 15, 2019

Primary Completion Date

November 11, 2020

Study Completion Date

November 11, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

Placebo

Administered as specified in the treatment arm.

DRUG

BIIB104

Administered as specified in the treatment arm.

Trial Locations (1)

NW10 7EW

Research Site, London

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY